v3.26.1
Other Current Liabilities - Summary of Other Current Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Other Liabilities Current [Line Items]    
Refundable deposit related to TJ Biopharma preferred shares sale [1] $ 7,533 $ 7,316
Withholding and value added taxes 599  
Incentive payment from depository bank 209  
Total other current liabilities 8,878 9,180
Bridge Health    
Other Liabilities Current [Line Items]    
Bridge Health acquisition cost [2] $ 537 $ 1,864
[1] In September 2025, the Group entered into an agreement with TJ Biopharma to facilitate the sale of the Group’s holding of TJ Biopharma’s preferred shares, whereby TJ Biopharma paid the Group a cash deposit. See the Company’s Annual Report for additional information.
[2] Represents the current portion of the non-contingent quarterly payments related to the Bridge Health acquisition. See Note 4 – Asset Acquisitions and Strategic Transactions for additional information.